- Title
- Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT
- Creators - without role
- Urban Novak - University Hospital of BernJarl Mooyaart - European Society for Blood and Marrow TransplantationMichael Daskalakis - University Hospital of BernChristof Scheid - University of CologneLudovic Gabellier - Centre Hospitalier Universitaire de MontpellierIbrahim Yakoub-Agha - Centre Hospitalier Universitaire de LilleRon Ram - Tel Aviv Sourasky Medical CenterEdouard Forcade - Hôpital Cardiologique du Haut-LévêqueLucía López-Corral - Instituto de Investigación Biomédica de SalamancaEmma Nicholson - Royal Marsden NHS Foundation TrustEugenio Galli - Università Cattolica del Sacro CuoreFriedrich Stölzel - University of LübeckWolfgang Bethge - University of TübingenEva Maria Wagner-Drouet - Johannes Gutenberg University MainzJorinde D Hoogenboom - European Society for Blood and Marrow TransplantationStephan Mielke - Karolinska University HospitalCaroline Arber - University Hospital of LausanneFederico Simonetta - Faculté de médecine [Genève]Christian Chabannon - Institut Paoli-CalmettesJürgen Kuball - Heidelberg UniversityAnnalisa Ruggeri - San Raffaele University of RomeFlorent Malard - Sorbonne Université
- Publication Details
- Bone Marrow Transplantation, Vol.59(11), pp.1631-1634
- Identifiers
- 9938478209311
- Academic Unit
- Université de Montpellier
- Language
- English
- Resource Type
- Journal article
- Local Fields
- hal-04909773
Journal article
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT
Bone Marrow Transplantation, Vol.59(11), pp.1631-1634
27/08/2024
PMID: 39192081
Metrics
1 Record Views